Enhanced Community Pharmacy service

CPV: Health and social work services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

11 Mar 2026, 15:52 GMT

Last source update

8 May 2026, 17:38 BST

FTS notice number

2026/S 000-042746

Classification (CPV)

Health and social work services

Delivery area

East Midlands (UKF21)

Official registry OCID

ocds-h6vhtk-066789 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.

The publication of this notice marks the start of the standstill period, which begins the day after this notice is published.

Representations by providers must be made to the relevant authority b ymidnight of the 23rd March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 23rd March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. - Details of the award decision-makers: NHS LNR ICB cluster Committees Meeting in Common for Finance and Contracting 03 March 2026 - How conflicts or potential conflicts of interest of individuals making the decision were managed: None were declared - Explanation of the relative importance of the PSR's key criteria: Relative importance of the key criteria: 1. Quality and innovation During the pilot and the existing contracting period all quality outcomes for service delivery with the provider were assured. Acceptable processes are in place to recognise and report patient safety incidents. Good processes in place to mitigate risks, their QS RAG rating was agreed as Good. 2. Value The provider has demonstrated how the service has delivered measurable value for money through reduced duplication, efficient resource utilisation, and the avoidance of unnecessary hospital admissions or escalation of care. 3. Integration, collaboration and service sustainability The service is delivered in an integrated way, and the provider has engaged fully with all system stakeholders through the Improving Access to Anticipatory Medications workgroup. The service is sustainable based on current activity levels which are as predicted and are on average 14 per week. 4. Improving access, reducing health inequalities and facilitating choice One of the primary objectives of the pilot was to improve access to medications in the community and the interim evaluation clearly shows that this has been achieved and is a marked improvement on the previous model. The service has ensured a reduction in inequalities, as patients receive medications regardless of their access to transport or ability to travel. The service facilitates choice for patients in relation to their preferred place of death / care, ensuring that pain and other symptoms can be managed at home in a timely and manageable way. 5. Social value Prior to the pilot, carers and family members were required to locate the medications prescribed which often involved visiting 4-5 separate pharmacies at a time when their loved one was in their last hours. The social value of enabling families to be at the bedside of their loved one is immeasurable.

• NUP S Corporation Ltd T/A Omcare Late Night PharmacyAwarded supplierGB-COH: 09774179 Leicester, East Midlands, LE4 5AU

No document links were published on the notice.